Skip to main content
Published locations for Resectable NSCLC: The addition of nivolumab to neoadjuvant chemotherapy is beneficial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Resectable NSCLC: The addition of nivolumab to neoadjuvant chemotherapy is beneficial
User login
Username
Password
Reset your password
/content/resectable-nsclc-addition-nivolumab-neoadjuvant-chemotherapy-beneficial
/hematology-oncology/article/254923/lung-cancer/resectable-nsclc-addition-nivolumab-neoadjuvant